MOTS-C: The Peptide Hiding Inside Your Mitochondria

Most peptides act like messages sent around the body. MOTS-C is different because the message appears to come directly from the mitochondria—the tiny energy centres inside your cells.

That is what makes the MOTS-C peptide so interesting.

Its full name is mitochondrial open reading frame of the 12S rRNA type-c, which is exactly why everyone simply calls it MOTS-C. In lay terms, it is a small peptide encoded within mitochondrial DNA that helps cells respond when energy is running low or the body is under metabolic stress (Lee et al., 2015).

Think of your mitochondria as more than batteries. They do not simply create energy; they also communicate with the rest of the body. MOTS-C appears to be one of those messages.

Why Is MOTS-C Called the “Exercise Peptide”?

Exercise forces your muscles to use fuel, adapt to stress and become more efficient. MOTS-C appears to interact with some of these same metabolic systems.

In a small human experiment involving 10 healthy young men, exercise increased MOTS-C levels in both skeletal muscle and the bloodstream. This suggested that MOTS-C may form part of the body’s natural response to physical activity (Reynolds et al., 2021).

That does not mean MOTS-C replaces exercise. It means researchers are interested in whether this mitochondrial peptide helps the body manage energy in an exercise-like way.

One important pathway involved is AMPK, sometimes described as the cell’s fuel gauge. When cellular energy becomes low, AMPK helps the body increase glucose uptake and use available fuel more efficiently.

Energy, Metabolism and Physical Performance

The strongest MOTS-C research so far has been conducted in animals.

In mice, MOTS-C improved insulin sensitivity and reduced the weight gain and metabolic disruption caused by a high-fat diet (Lee et al., 2015).

Later research found that MOTS-C improved running capacity in young, middle-aged and older mice. Treatment started late in life also delayed aspects of age-related physical decline and helped older mice maintain physical function for longer (Reynolds et al., 2021).

This explains why MOTS-C is increasingly discussed in conversations about:

Energy, endurance, insulin sensitivity, metabolic health and healthy ageing.

However, these findings should not be confused with proven human benefits. A mouse running farther on a treadmill does not establish that an injectable MOTS-C product will improve human athletic performance, fat loss or longevity.

Is MOTS-C the Next Big Peptide?

Possibly—but it is still early.

A registered 12-week human trial has been designed to investigate whether MOTS-C can improve insulin sensitivity and cardiometabolic markers in people showing early metabolic dysfunction.

That study matters because most of the excitement surrounding MOTS-C currently comes from laboratory and animal research rather than large controlled human trials.

MOTS-C is fascinating because it changes how we think about mitochondria. They may not simply power the cell; they may actively send messages that influence how the body handles stress, glucose and energy.

The science is promising. The hype is already here. The human evidence still needs to catch up.

References

Lee, C., Zeng, J., Drew, B. G., Sallam, T., Martin-Montalvo, A., Wan, J., Kim, S. J., Mehta, H., Hevener, A. L., de Cabo, R., & Cohen, P. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 21(3), 443–454. https://doi.org/10.1016/j.cmet.2015.02.009

Reynolds, J. C., Lai, R. W., Woodhead, J. S. T., Joly, J. H., Mitchell, C. J., Cameron-Smith, D., Lu, R., Cohen, P., Graham, N. A., Benayoun, B. A., & Lee, C. (2021). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications, 12, Article 470. https://doi.org/10.1038/s41467-020-20790-0